“When asked about new therapies, most neurologists wanted those that “Provide added years of life (maintaining quality of life), not months of life.”
Interesting I know of a promising new drug that might fit that bill….
https://alsnewstoday.com/news/neurologists-frustrated-with-als-treatments-now-on-market-study/
Amylyx class action Relyvrio, page-13
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $94.81M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 19.5¢ | $156.3K | 798.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 735 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 381328 | 11 |
View Market Depth
| Last trade - 15.20pm 01/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |